Martingale Asset Management’s AnaptysBio ANAB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.56M	Buy	+28,142	New	+$1.51M	0.04%	395
2025 Q1	–	Sell	-28,995	Closed	-$384K	–	771
2024 Q4	$384K	Hold	28,995	–	–	0.01%	647
2024 Q3	$971K	Buy	28,995 +360	+1%	+$12.3K	0.02%	461
2024 Q2	$718K	Hold	28,635	–	–	0.02%	523
2024 Q1	$645K	Buy	28,635 +16	+0.1%	+$379	0.01%	564
2023 Q4	$613K	Hold	28,619	–	–	0.01%	560
2023 Q3	$514K	Hold	28,619	–	–	0.01%	607
2023 Q2	$582K	Buy	28,619 +1,702	+6%	+$34.5K	0.01%	583
2023 Q1	$586K	Buy	26,917 +800	+3%	+$19.4K	0.01%	582
2022 Q4	$809K	Buy	26,117 +7	+0%	+$198	0.02%	518
2022 Q3	$667K	Buy	26,110 +2,500	+11%	+$58.6K	0.01%	551
2022 Q2	$480K	Buy	23,610 +1,101	+5%	+$24.4K	0.01%	648
2022 Q1	$558K	Sell	22,509 -2,700	-11%	-$81.7K	0.01%	618
2021 Q4	$877K	Sell	25,209 -8,305	-25%	-$263K	0.01%	529
2021 Q3	$910K	Buy	33,514 +13,800	+70%	+$350K	0.01%	529
2021 Q2	$512K	Buy	19,714 +1,701	+9%	+$40.8K	0.01%	585
2021 Q1	$390K	Buy	18,013 +5,197	+41%	+$131K	﹤0.01%	680
2020 Q4	$276K	Sell	12,816 -4,802	-27%	-$117K	﹤0.01%	759
2020 Q3	$260K	Hold	17,618	–	–	﹤0.01%	933
2020 Q2	$394K	Buy	17,618 +297	+2%	+$5.43K	﹤0.01%	913
2020 Q1	$245K	Sell	17,321 -1,091	-6%	-$16.5K	﹤0.01%	905
2019 Q4	$300K	Buy	+18,412	New	+$435K	﹤0.01%	920